Premier Research is dedicated to helping patients and families around the world overcome the burden of debilitating diseases, such as a cancer diagnosis.

Cancer is a leading cause of death for children and adolescents, and there are approximately 300,000 children diagnosed with cancer each year around the world.¹ With the help of better therapies, more than 80 percent of U.S. childhood cancer patients are becoming long-term survivors.²

In honor of National Childhood Cancer Awareness Month in the United States, Premier Research is highlighting an organization that offers resources to help patients and their families in the fight against a childhood cancer diagnosis.

Alex’s Lemonade Stand

One of the many cancer organizations that Premier supports is Alex’s Lemonade Stand. Alex’s Lemonade Stand Foundation is changing the lives of children with cancer by funding impactful research, raising awareness, and helping support families. The foundation offers numerous resources for childhood cancer patients, their parents, and their siblings dealing with a childhood cancer diagnosis in the family. Learn more about the foundation and how they aim to help researchers, scientists, and doctors get closer to a childhood cancer cure.

Premier Research is proud to celebrate several years of participation in Lemonade Days for Alex’s Lemonade Stand Foundation. The company first participated in 2012, where employees around the country set up lemonade stands at their office locations to raise funds for the foundation. In 2019, Premier Research’s Quincy, Massachusetts, office participated for the fifth year to raise funds for this important organization. To date, Premier Research has helped raise more than $7,500 and has helped fund more than 151 hours of research.

While a cancer diagnosis is not easy to cope with, Premier Research hopes that the foundation’s resources will make it easier for patients and their families to navigate the process of undergoing treatment.

Premier Research resources for biotechs and specialty pharma

Premier Research has a diversely talented team of oncology experts who have managed more than 170 oncology trials over the past five years. We pair our oncology development expertise with wide-ranging rare disease experience in the largest areas of unmet need. We have come together to provide the resources below for sponsors who are at various stages in their pediatric oncology clinical trials.

Planning for pediatric oncology trials can be a daunting task. With the shift from indication to molecular target, sponsors face the challenge of reassessing and prioritizing their pipelines. Sponsors can find key considerations for operationalizing pediatric oncology trials in this blog post.

The industry’s regulatory landscape is continually evolving, and the demand for innovative therapies targeting pediatric cancers is becoming increasingly vocal. The FDA’s Research to Accelerate Cures and Equity (RACE) for Children Act went into effect on August 18, 2020. Learn about the regulatory changes for pediatric oncology trials in our guide.

To learn more about how Premier Research can support your pediatric oncology clinical trial, visit our Oncology & Hematology Clinical Trial Experience resource page.

[1] Cancer in Children, World Health Organization, 2018, https://www.who.int/news-room/fact-sheets/detail/cancer-in-children

[2] Childhood Cancer Facts, St. Jude Children’s Research Hospital, https://www.stjude.org/treatment/pediatric-oncology/childhood-cancer-facts.html